The global urology devices market size was estimated to be USD 34.79 billion in 2023 and is expected to reach at USD 77.40 billion by 2034 with a CAGR of 7.54% during the forecast period 2024-2034. Increasing prevalence of urologic conditions, growing aging population, rising adoption of single-use cystoscopes, surge in research & development activities, increasing mergers & acquisitions within market players, growing focus on development of innovative devices, rising launch of new products, surge in demand for early diagnosis & treatment of diseases, rising adoption of minimally invasive procedures, and growing technological advancements are some of the primary factors driving the market expansion.
Growing technological advancements is predicted to boost the market growth during the forecast period. The rising incidence of urology-related conditions like urethral malignancies, end-stage renal diseases, chronic kidney diseases, and urolithiasis has prompted healthcare experts and manufacturers to boost research and development efforts to introduce more advanced urology devices. For instance, in February 2023, Ethicon, Inc. has revealed the inaugural use of the Monarch platform for robotic-assisted kidney stone removal. This method contributes to lowering the likelihood of needing further treatment post-kidney stone removal, thereby reducing complications and associated risks.
By product, accessories was the highest revenue-grossing segment in the global urology devices market in 2023 owing to the rising launch of urological accessories, surge in number of patient visits to urology clinics, and growing adoption of catheters & dilators in the urology clinics for treatment. Additionally, endoscopes is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of urolithiasis, increasing demand for disposable cystoscopes, and surge in product approvals by regulatory bodies. For instance, in February 2022, The U.S. FDA has granted approval for KARL STORZ SE & Co. KG to utilize its Blue Light system alongside Photocure ASA's Cysview product in Blue Light Cystoscopy procedures, aiding in the identification of non-muscle-invasive bladder cancer (NMIBC).
By application, kidney diseases was the highest revenue-grossing segment in the global urology devices market in 2023 owing to the rising demand for early diagnosis & treatment of kidney disorders, growing prevalence of CKD, surge in awareness among population, increasing focus on development of low-cost & effective treatment, rising demand for dialysis & minimally invasive procedures, and growing mergers & acquisitions within market players. For instance, in September 2022, Advanced MedTech Solutions Pvt. has completed the acquisition of Shenzhen Huikang Medical Apparatus Co., Ltd., a prominent player in the Chinese urology market. This move is intended to enhance their market presence in China. Additionally, bladder disorder is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of geriatric population susceptible to bladder infections, diabetes, & urinary tract infections causing bladder control problems and increasing demand for early diagnosis of urological diseases.
By end-user, hospitals & ambulatory surgical centers was the highest revenue-grossing segment in the global urology devices market in 2023 owing to surge in number of patient visits with urology-related disorders within hospitals, rising adoption of urology endoscopes such as cystoscopes & ureteroscopes, growing adoption of minimally invasive procedures, and surge in demand for treatment & diagnosis of urolithiasis. Additionally, dialysis centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing number of patients suffering from kidney failure disorders in dialysis centers, growing awareness regarding to dialysis, and rising focus on expansion by market players. For instance, in April 2022, NephroPlus has revealed the inauguration of two additional dialysis facilities, with one located in Urgench and the other in Bogot, Uzbekistan. Furthermore, the company has intentions to launch its fourth center in Tashkent in the near future.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising focus on upgrading available devices, increasing innovations related to diagnostic methodologies used for UTIs, surge in technological advancements, growing number of urology cases in hospitals, rising funding by major market players, and increasing focus on development of innovative products. For instance, in December 2022, Precision Optics Corporation, Inc., a company specializing in advanced optical instruments for medical and defense applications, has disclosed a recent order for the development of a new single-use urology program. This initiative is part of the company's strategy to broaden its presence in the medical device market. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing healthcare infrastructure, increasing awareness regarding the diagnosis of urology disorders, rising technological advancements, and surge in initiatives by market players. For instance, in June 2022, Austrak Pvt. Ltd., a pharmaceutical company headquartered in Hyderabad, has introduced a new division specializing in nephrology and urology as part of its mission to provide products and services for the prevention, diagnosis, and treatment of diseases in these fields.
Growing technological advancements is predicted to boost the market growth during the forecast period. The rising incidence of urology-related conditions like urethral malignancies, end-stage renal diseases, chronic kidney diseases, and urolithiasis has prompted healthcare experts and manufacturers to boost research and development efforts to introduce more advanced urology devices. For instance, in February 2023, Ethicon, Inc. has revealed the inaugural use of the Monarch platform for robotic-assisted kidney stone removal. This method contributes to lowering the likelihood of needing further treatment post-kidney stone removal, thereby reducing complications and associated risks.
By product, accessories was the highest revenue-grossing segment in the global urology devices market in 2023 owing to the rising launch of urological accessories, surge in number of patient visits to urology clinics, and growing adoption of catheters & dilators in the urology clinics for treatment. Additionally, endoscopes is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of urolithiasis, increasing demand for disposable cystoscopes, and surge in product approvals by regulatory bodies. For instance, in February 2022, The U.S. FDA has granted approval for KARL STORZ SE & Co. KG to utilize its Blue Light system alongside Photocure ASA's Cysview product in Blue Light Cystoscopy procedures, aiding in the identification of non-muscle-invasive bladder cancer (NMIBC).
By application, kidney diseases was the highest revenue-grossing segment in the global urology devices market in 2023 owing to the rising demand for early diagnosis & treatment of kidney disorders, growing prevalence of CKD, surge in awareness among population, increasing focus on development of low-cost & effective treatment, rising demand for dialysis & minimally invasive procedures, and growing mergers & acquisitions within market players. For instance, in September 2022, Advanced MedTech Solutions Pvt. has completed the acquisition of Shenzhen Huikang Medical Apparatus Co., Ltd., a prominent player in the Chinese urology market. This move is intended to enhance their market presence in China. Additionally, bladder disorder is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of geriatric population susceptible to bladder infections, diabetes, & urinary tract infections causing bladder control problems and increasing demand for early diagnosis of urological diseases.
By end-user, hospitals & ambulatory surgical centers was the highest revenue-grossing segment in the global urology devices market in 2023 owing to surge in number of patient visits with urology-related disorders within hospitals, rising adoption of urology endoscopes such as cystoscopes & ureteroscopes, growing adoption of minimally invasive procedures, and surge in demand for treatment & diagnosis of urolithiasis. Additionally, dialysis centers is predicted to grow at fastest CAGR during the forecast period owing to the increasing number of patients suffering from kidney failure disorders in dialysis centers, growing awareness regarding to dialysis, and rising focus on expansion by market players. For instance, in April 2022, NephroPlus has revealed the inauguration of two additional dialysis facilities, with one located in Urgench and the other in Bogot, Uzbekistan. Furthermore, the company has intentions to launch its fourth center in Tashkent in the near future.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising focus on upgrading available devices, increasing innovations related to diagnostic methodologies used for UTIs, surge in technological advancements, growing number of urology cases in hospitals, rising funding by major market players, and increasing focus on development of innovative products. For instance, in December 2022, Precision Optics Corporation, Inc., a company specializing in advanced optical instruments for medical and defense applications, has disclosed a recent order for the development of a new single-use urology program. This initiative is part of the company's strategy to broaden its presence in the medical device market. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing healthcare infrastructure, increasing awareness regarding the diagnosis of urology disorders, rising technological advancements, and surge in initiatives by market players. For instance, in June 2022, Austrak Pvt. Ltd., a pharmaceutical company headquartered in Hyderabad, has introduced a new division specializing in nephrology and urology as part of its mission to provide products and services for the prevention, diagnosis, and treatment of diseases in these fields.
Segmentation: Urology Devices Market Report 2023 - 2034
Urology Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Endoscopes
- Ureteroscopes
- Cystoscopes
- Others
- Dialysis Devices
- Accessories
- Laser & Lithotripsy Devices
- Others
Urology Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Bladder Disorders
- Kidney Disease
- Urolithiasis
- Urethral Malignancies
- Others
Urology Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Dialysis Centers
- Hospitals & Ambulatory Surgical Centers
- Others
Urology Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Urology Devices Market: Product Estimates & Trend Analysis
8. Urology Devices Market: Application Estimates & Trend Analysis
9. Urology Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Urology Devices Market
12. Europe Global Urology Devices Market
13. Asia Pacific Global Urology Devices Market
14. Latin America Global Urology Devices Market
15. MEA Global Urology Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Siemens
- KARL STORZ SE & Co. KG
- Abbott
- Endo Pharmaceuticals Inc
- Cardinal Health
- BD
- Boston Scientific Corporation
- Intuitive Surgical
- Baxter
- Medtronic
- Coloplast Corp
- Richard Wolf GmbH
- Stryker
- Johnson & Johnson Services Inc.
- MEDI TECH DEVICES PVT LTD
- Olympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 34.79 Billion |
| Forecasted Market Value ( USD | $ 77.4 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
